Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
In previous work, we have shown that local administration of active cyclophosphamide (CY) derivatives, or other cytostatic drugs, at the sensitization site induced a similar immunopotentiation to that of systemic CY. Since it is well documented that CY can inhibit suppressor cells, it was proposed that immunoenhancement by locally administered drugs might be based on a similar principle. The objective of the present study was to test this hypothesis, using an experimental model of Ts mediated suppression of delayed type hypersensitivity to sheep erythrocytes. In this model, mice are made tolerant to sheep erythrocytes by i.v. injection of a high dose of sheep erythrocytes. Local treatment of sheep erythrocytes-tolerant mice with the active CY derivative Z7557 at the site of attempted sensitization reversed suppression in a dose-dependent manner. Local treatment with the cytostatic drug etoposide (VP-16) and systemic CY treatment were also effective. In transfer experiments, the function of afferently acting suppressor cells was blocked by local treatment with Z7557 or systemic CY. These data support the concept of anti-suppressor cell activity of locally administered cytostatic drugs. As with CY, the pharmacological basis of this effect remains to be determined.
Limpens
J
J
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Scheper
R J
RJ
D000287:Administration, Topical; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004912:Erythrocytes / Q000276:immunology; D006968:Hypersensitivity, Delayed / Q000209:etiology; D051379:Mice; D008807:Mice, Inbred BALB C; D012756:Sheep; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*
D000970:Antineoplastic Agents; C048341:mafosfamide; D003520:Cyclophosphamide